Aurobindo Pharma
BSE: 524804 | NSE: AUROPHARMA | ISIN: INE406A01037 | SECTOR: Major DrugsOpen
407.55High
411.45Low
397.30Prev Close
409.90P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
-Volume
38.26KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
403.90Ask
-
Promoter Pledge Holding - 8.37%
Promoter Name | No of Shares | Percentage |
---|---|---|
K NITYANANDA REDDY | 1,00,55,000 | 1.71% |
KIRTHI REDDY KAMBAM | 19,00,000 | 0.32% |
KAMBAM SPOORTHI | 4,00,000 | 0.06% |
KOTTAMANCHI RAJESHWARI | 2,00,000 | 0.03% |
M SUMANTH KUMAR REDDY | 8,00,000 | 0.13% |
RPR SONS ADVISORS PRIVATE LIMITED, MRS.P.SUNEELA RANI (JOINTLY HOLDING) | 3,11,95,862 | 5.32% |
AXIS CLINICALS LIMITED, TRIDENT CHEMPHAR LIMITED, RPR SONS ADVISORS PVT.LTD. (JOINTLY HOLDING) | 37,50,000 | 0.63% |
PRASADA REDDY KAMBHAM | 1,00,000 | 0.01% |
AXIS CLINICALS LIMITED | 6,58,000 | 0.11% |
Company Description
- Major Drugs
BSE
524804NSE
AUROPHARMAISIN
INE406A01037
Aurobindo Pharma Limited is an India-based pharmaceutical company. The Company develops, manufactures and distributes generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients. Its product portfolio is spread over seven therapeutic/product areas encompassing central nervous systems (CNS), anti-retroviral, cardiovascular (CVS), antibiotics, gastroenterological, anti-diabetics and anti-allergic. It is engaged in developing a range of oncology and hormonal products. It is developing topical as well as transdermal products in the dermatology therapeutic segment. It is also developing about three depot injections based on the microsphere and nano-suspension technology platforms. The Company is marketing its products globally in approximately 150 countries. The Company's subsidiaries include APL Healthcare Limited, Auronext Pharma Private Limited, Auro Peptides Limited, APL Pharma Thai Limited and Aurolife Pharma LLC, among others.
Company Officers
K. Nityananda Reddy
Vice Chairman of the Board, Managing DirectorSanthanam Subramanian
Chief Financial OfficerB. Adi Reddy
Compliance Officer, Company SecretaryM. Madan Reddy
Whole-Time DirectorP. Sarath Reddy
Whole-Time DirectorM. Sivakumaran
Whole-Time Director